Alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism are both ATP1A3-related disorders by unknown
MEETING ABSTRACT Open Access
Alternating hemiplegia of childhood and
rapid-onset dystonia-parkinsonism are both
ATP1A3-related disorders
Hendrik Rosewich1*, Holger Thiele2, Andreas Ohlenbusch1, Ulrike Maschke3, Peter Frommolt2, Peter Nürnberg2,
Knut Brockmann4, Jutta Gärtner1
From 50th Workshop for Pediatric Research
Gottingen, Germany. 20-21 March 2014
Alternating hemiplegia of childhood (AHC) was first
described as a distinctive disease in 1971 [1]. The disease
is characterised by early-onset episodes of hemiplegia, dys-
tonia, numerous paroxysmal symptoms, and developmen-
tal impairment [2]. Almost all cases of AHC are sporadic.
To identify de-novo mutations associated with this dis-
ease 40 clinically well-characterized patients were
recruited from September 2004 till April 2013. Whole-
exome sequencing was performed in three proband-parent
trios. Informative genes were evaluated in the 37 remain-
ing patients and ATP1A3 emerged as the gene associated
with AHC [3]. Interestingly, this gene was already known
to be associated with another movement disorder with
later onset namely rapid-onset dystonia-parkinsonism
(RDP) [4]. We then thoroughly analysed clinical and mole-
cular findings of AHC and RDP to evaluate the phenotypic
and genotypic spectrum. In addition, we started to analyse
the functional consequences of the encoded Na+,K+ alpha
3 subunit for different ATP1A3 mutations associated
with either AHC or RDP applying cell survival assays and
two-electrode voltage clamp techniques.
39 of 40 patients with a characteristic AHC/RDP phe-
notype displayed a de-novo mutation in ATP1A3. Our
study first showed that AHC and RDP are not two dis-
tinct diseases but rather constitute a clinical continuum
of one disorder with AHC at the severe end of the spec-
trum and RDP as a milder variant. Clinically overlapping
features are abrupt onset of triggered dystonic episodes, a
rostrocaudal gradient of involvement as well as brainstem
dysfunction; clearly differentiating characteristics are
fixed dystonia in RDP and episodic hemiplegia in AHC.
Further, mutations affecting functional and transmem-
brane protein domains tend to be associated with an
AHC phenotype and the majority of ATP1A3 mutations
are located in only four exons [5]. To further elucidate
the pathomechanisms of ATP1A3 related disorders in
vitro studies on selected mutations are ongoing.
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